1-7 of 7
Audrey Mauguen
Close
Sort by
Journal Articles

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

Christopher J. Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca J. Deyell, Jamie E. Flerlage, Anna K. Franklin, Jennifer Krajewski, Kasey J. Leger, Lianna J. Marks, Robin E. Norris, Martha Pacheco, Faye Willen, Adam Paul Yan, Paul D. Harker-Murray, Lisa Giulino-Roth
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3225–3231.
https://doi.org/10.1182/bloodadvances.2022009323
Published: 2023
Includes: Supplemental data
Journal Articles

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML

Kavitha Ramaswamy, Peter G. Steinherz, Anurag K. Agrawal, Christopher J. Forlenza, Audrey Mauguen, Mikhail Roshal, Tanya Trippett, Nancy A. Kernan, Maria Luisa Sulis, Neerav Shukla
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2688–2694.
https://doi.org/10.1182/bloodadvances.2021005753
Published: 2022
Includes: Supplemental data
Journal Articles

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Clinical Trials & Observations
Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Steven P. Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz, Kevin J. Curran
Journal: Blood Advances
Blood Adv (2022) 6 (7): 1961–1968.
https://doi.org/10.1182/bloodadvances.2021006418
Published: 2022
Includes: Supplemental data
Journal Articles

Antithymocyte globulin exposure in CD34 + T-cell–depleted allogeneic hematopoietic cell transplantation

Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, Christina Cho, Sean Devlin, Josel D. Ruiz, Elizabeth Klein, Scott T. Avecilla, Farid Boulad, Maria I. Cancio, Kevin J. Curran, Ann A. Jakubowski, Nancy A. Kernan, Andrew L. Kung, Richard J. O’Reilly, Esperanza B. Papadopoulos, Susan Prockop, Ichelle van Roessel, Andromachi Scaradavou, Brian C. Shaffer, Gunjan Shah, Barbara Spitzer, Roni Tamari, Sergio A. Giralt, Miguel-Angel Perales, Jaap Jan Boelens
Journal: Blood Advances
Blood Adv (2022) 6 (3): 1054–1063.
https://doi.org/10.1182/bloodadvances.2021005584
Published: 2022
Includes: Supplemental data
Journal Articles

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma

Clinical Trials & Observations
Christopher J. Forlenza, Nitya Gulati, Audrey Mauguen, Michael J. Absalon, Sharon M. Castellino, Anna Franklin, Frank G. Keller, Neerav Shukla
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5519–5524.
https://doi.org/10.1182/bloodadvances.2021005268
Published: 2021
Journal Articles

Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4 + immunity to mediate durable responses

Clinical Trials & Observations
Vanessa A. Fabrizio, M. Irene Rodriguez-Sanchez, Audrey Mauguen, Parastoo B. Dahi, Ekaterina Doubrovina, Richard J. O’Reilly, Susan E. Prockop
Journal: Blood Advances
Blood Adv (2021) 5 (2): 496–503.
https://doi.org/10.1182/bloodadvances.2020002735
Published: 2021
Journal Articles

Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information

Clinical Trials & Observations
Reiko Nakajima, Alison J. Moskowitz, Laure Michaud, Audrey Mauguen, Connie Lee Batlevi, Ahmet Dogan, Heiko Schöder
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1812–1823.
https://doi.org/10.1182/bloodadvances.2020001579
Published: 2020
Includes: Supplemental data